Since we are on the cusp of the most important stage of Paxalisib's validation process for trial registration. Posters link to GBM AGILE.
"GBM AGILE is an entirely unique approach to clinical trials made possible by the partnership and collaboration of clinicians, researchers, governments, regulatory agencies, pharmaceutical companies, and patient advocacy groups."
"This new clinical trial approach is advantageous to GBM patients because
it will help to identify effective treatments faster, allowing researchers to simultaneously and dynamically study the effects of multiple unique drugs."
https://www.gcaresearch.org/gbm-agile/Regards
